Pipeline Programs↗
Active Trials↗
Companies Involved↗
Back pain is a moderately active landscape with 45 programs across 73 companies. 3 programs are in Phase 3.
Intelligence
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Analysis
98%
Small molecule
40 of 41 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 41 classified programs, each share of the total. Modality classified for 98% of 45 pipeline programs.
Analysis
472
clinical trials
Clinical Trials
472 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)